CD8A and neoplasm: A greater number of MHC class I molecules can bind more antigenic peptides and present them on the cell surface, increasing opportunities for recognition by CD8+ T cells, thereby enhancing the immune system’s surveillance and killing capacity against tumor cells or infected cells [52].